FDA Blocks Monoclonal Antibody Treatments

Jason Perry
By Jason Perry
January 25, 2022NTD Evening Newsshare

The Food and Drug Administration is now restricting the use of monoclonal antibody treatments for COVID-19. They say the data shows such treatments are “highly unlikely” to work against the Omicron variant.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments